» Articles » PMID: 25449516

Different Patterns of Myocardial Iron Distribution by Whole-heart T2* Magnetic Resonance As Risk Markers for Heart Complications in Thalassemia Major

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2014 Dec 3
PMID 25449516
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The multislice multiecho T2* cardiovascular magnetic resonance (CMR) technique allows to detect different patterns of myocardial iron overload (MIO). The aim of this cross-sectional study was to verify the association between cardiac complications (heart failure and arrhythmias), biventricular dysfunction and myocardial fibrosis with different patterns of MIO in thalassemia major (TM) patients.

Methods: We considered 812 TM patients enrolled in the Myocardial Iron Overload in Thalassemia (MIOT) Network. The T2* value in all the 16 cardiac segments was evaluated.

Results: We identified 4 groups of patients: 138 with homogeneous MIO (all segments with T2* < 20 ms), 97 with heterogeneous MIO (some segments with T2* < 20 ms, others with T2* ≥ 20 ms) and significant global heart iron (global heart T2* < 20 ms), 238 with heterogeneous MIO and no significant global heart iron, and 339 with no MIO (all segments with T2* ≥ 20 ms). Compared to patients with no MIO, patients with homogeneous MIO were more likely to have cardiac complications (odds ratio-OR = 2.67), heart failure (OR = 2.54), LV dysfunction (OR = 5.59), and RV dysfunction (OR = 2.26); patients with heterogeneous MIO and significant global heart iron were more likely to have heart failure (OR = 2.38) and LV dysfunction (OR = 2.39).

Conclusions: Cardiac complications, heart failure and dysfunction were correlated with MIO distribution with an increasing risk from the TM patients with no MIO to those with homogeneous MIO. Using a segmental approach, early iron deposit or homogeneous MIO patterns can be characterized to better tailor chelation therapy.

Citing Articles

Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects.

Ru Q, Li Y, Zhang X, Chen L, Wu Y, Min J Bone Res. 2025; 13(1):27.

PMID: 40000618 PMC: 11861620. DOI: 10.1038/s41413-024-00398-6.


Left ventricular diastolic and systolic functions by cardiac magnetic resonance in beta-thalassemia major: correlation with clinical findings and cardiac complications.

Meloni A, Saba L, Positano V, Taccori M, Pistoia L, De Marco E Int J Cardiovasc Imaging. 2025; .

PMID: 39928284 DOI: 10.1007/s10554-025-03352-7.


Assessment of cardiac iron deposition and genotypic classification in pediatric beta-thalassemia major: the role of cardiac MRI.

Zhang S, Zhao W, Sun L, Liang G, Wang X, Zeng H BMC Med Imaging. 2025; 25(1):31.

PMID: 39885407 PMC: 11783902. DOI: 10.1186/s12880-025-01567-7.


Magnetic Resonance Evaluation of Tissue Iron Deposition and Cardiac Function in Adult Regularly Transfused Thalassemia Intermedia Compared with Thalassemia Major Patients.

Meloni A, Pistoia L, Ricchi P, Longo F, Cecinati V, Sorrentino F J Clin Med. 2024; 13(16).

PMID: 39200932 PMC: 11355279. DOI: 10.3390/jcm13164791.


Association between Epicardial Adipose Tissue and Atrial Fibrillation in Patients with Transfusion-Dependent β-Thalassemia.

Malagu M, Tonet E, Orazio G, Longo F, De Raffele M, Sirugo P J Clin Med. 2024; 13(12).

PMID: 38930000 PMC: 11205093. DOI: 10.3390/jcm13123471.